Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Is How Amgen Avoided a Catastrophic Q1 Update


After U.S. stock markets closed on Tuesday, Amgen (NASDAQ: AMGN) disappointed investors by missing analyst expectations on the top and bottom lines. First-quarter sales of the company's drugs have been impacted by the COVID-19 pandemic, as repeated outbreaks make it harder for patients with other conditions to seek treatment.

The situation is bad enough that the company lowered adjusted earnings expectations for 2021 to a range of between $9.11 and $10.71 per share, from a previous prediction that ranged between $12.12 and $13.17 per share.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments